Baxter International Inc (BAX) Growth Rates Comparisons to Medical Equipment & Supplies Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Suppliers, else..
 
Baxter International Inc   (NYSE: BAX)
 

Baxter International Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BAX Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 8.36 % 6.57 % 8.91 % 10.9 %
Q / Q Revenue Growth (Q2 MRQ) 12.74 % -1.87 % -3.28 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 6.14 % 7.21 % 7.98 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) 2.08 % 1.5 % 2.03 % 2.61 %
Revenue 5 Year Average Growth -0.75 % 10.68 % 8.65 % 10.59 %


BAX's Growth Comparisons in II. Quarter 2026




Comparing 8.36% year on year Revenue growth in the second quarter 2026, Baxter International Inc outperformed the 6.57% growth in the Medical Equipment & Supplies industry, but Baxter International Inc 's growth compares unfavorably, to the 8.91% Revenue growth in the Healthcare sector.

Top-line improved by 12.74% from the first quarter. Looking into annual sales rise of -0.75%, and S & P 500's average yearly sales growth is 10.59% over the five years, including only Businesses with the second quarter 2026 Results. Baxter International Inc grew less than the market.

BAX Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
2022
-16.67 %
-
2023
-28.57 %
-
2024
-10 %
-
2025
-27.27 %
-
2026
-
-
United States
-3.69 %
-
International
11.54 %
-
Medical Products Therapies
1.82 %
-
Healthcare Systems Technologies
0.14 %
-
Pharmaceuticals
6.88 %
-
United States Medical Products Therapies
-5.21 %
-
United States Healthcare Systems Technologies
-0.97 %
-
United States Pharmaceuticals
-7.69 %
-
International Medical Products Therapies
11.44 %
-
International Healthcare Systems Technologies
3.23 %
-
International Pharmaceuticals
14.25 %
-
Infusion Therapies Technologies Medical Products Therapies
-1.31 %
-
Infusion Therapies Technologies United States Medical Products Therapies
-9.93 %
-
Infusion Therapies Technologies International Medical Products Therapies
10.98 %
-
Advanced Surgery Medical Products Therapies
13.43 %
-
Advanced Surgery United States Medical Products Therapies
13.79 %
-
Advanced Surgery International Medical Products Therapies
13.01 %
-
Care Connectivity Solutions Healthcare Systems Technologies
1.87 %
-
Care Connectivity Solutions United States Healthcare Systems Technologies
-0.32 %
-
Care Connectivity Solutions International Healthcare Systems Technologies
8.11 %
-
Front Line Care Healthcare Systems Technologies
-2.53 %
-
Front Line Care United States Healthcare Systems Technologies
-1.98 %
-
Front Line Care International Healthcare Systems Technologies
-4 %
-
Injectables Anesthesia Pharmaceuticals
-10.15 %
-
Injectables Anesthesia United States Pharmaceuticals
-7.69 %
-
Injectables Anesthesia International Pharmaceuticals
-13.57 %
-
Drug Compounding Pharmaceuticals
30.08 %
-
Drug Compounding International Pharmaceuticals
30.08 %
-
Other
15.38 %
-
Other United States
6.25 %
-
Other International
30 %
-
Total
2.9 %
-75.98 %


Growth Rates of BAX's Income in the second quarter 2026


BAX Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) 13.61 % 11.6 % 4.62 % 97.6 %
Sequential Operating Income Change (Q2 MRQ) 228.79 % 96.14 % 0.89 % 48.13 %
Y / Y Operating Income Growth (Q2 TTM) - 13.68 % 30.73 % 40.67 %
Sequential Operating Income Growth (Q2 TTM) - 2.92 % 4.82 % 20.86 %
Operating Income 5 Year Avg. Change - 11.5 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) 10.66 % -10.42 % -25.98 % 90.69 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) - 19.69 % -66.16 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) - 16.79 % 2.68 % 57.33 %
Sequential Income from Cont. Ops. Change (Q2 TTM) - -2.7 % -5.02 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change - 5.35 % 0.17 % -28.52 %

BAX Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) 38.46 % -12.37 % -26.26 % 90.69 %
Q / Q Net Income Growth (Q2 MRQ) - 44.98 % -0.77 % 27.07 %
Y / Y Net Income Change (Q2 TTM) - -0.27 % 15.51 % 57.33 %
Sequential Net Income Change (Q2 TTM) - -3.32 % -6.72 % 18.65 %
Net Income 5 Year Avg. Growth - 4.12 % 9.21 % 22.96 %

BAX's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) 8.33 % -16.23 % -25.98 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) - 15.71 % -66.16 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) - - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth - -1.8 % 0.17 % -28.52 %



BAX EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) 33.33 % -18.05 % -26.26 % -28.52 %
Q / Q EPS Net Growth (Q2 MRQ) - 40.16 % -0.77 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) - - - 4.93 %
EPS Net 5 Year Avg. Change - 4.12 % 9.21 % 22.96 %



Baxter International Inc showed impressive 33.33% year on year rise in the second quarter to $0.24, despite the -18.05% inMedical Equipment & Supplies industry, Healthcare sector dropped -26.26%. Slow second quarter 2026 income per share, in Medical Equipment & Supplies industry and Healthcare sector, were portrayed in the Baxter International Inc results which underperformed overall market.

The bottom-line improved by 12.74% from the first quarter. Looking into annual income per share rise of -0.75%, and S & P 500's average yearly income per share growth is 22.96% over the five years, including only Businesses with the second quarter 2026 earnings reports. Baxter International Inc grew less than the market.

BAX Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) 144.12 % 63.77 % 48.49 % 48.62 %
Sequential Free Cash Flow Change (Q2 MRQ) 118.42 % -54.09 % -46.96 % 34.18 %
Y / Y Free Cash Flow Change (Q2 TTM) 136.6 % 39.68 % 18.61 % 60.27 %
Sequential Free Cash Flow Change (Q2 TTM) 13.55 % 8.02 % 5.39 % 15.75 %
Free Cash Flow 5 Year Avg. Change -22.12 % 3.81 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q2 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q2 TTM) - - - 209.43 %
Sequential Net Cash Flow Change (Q2 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change - -9.69 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) -20.13 % 4.81 % 8.23 % 120.03 %
Sequential Capital Expenditures Change (Q2 MRQ) -13.14 % -21.5 % -22.09 % 36.87 %
Y / Y Capital Expenditures Change (Q2 TTM) 19.14 % -1.63 % 7.87 % 109.38 %
Sequential Capital Expenditures Change (Q2 TTM) -5.68 % -1.55 % 1.6 % 23.05 %
Capital Expenditures 5 Year Avg. Change -6.27 % 8.3 % 9.12 % 14.73 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.